MRC Technology Supports the ENTENTE Professional Exchange Program
News Apr 30, 2013
MRC Technology has announced its support for the ENTENTE Professional Exchange Program by becoming one of the initiative’s first hosting organizations.
Considered a leading technology transfer office (TTO), MRC Technology will offer qualifying candidates a unique opportunity to develop technology transfer experience and expertise by working directly alongside MRC Technology business professionals and subject experts.
The primary focus of the exchange program is to strengthen knowledge transfer offices in universities, public research organizations, and hospitals, and to promote trans-national collaboration between industry and academia in the health sector.
MRC Technology will provide participating Technology Transfer Officers with a clearer understanding of processes and priorities, and a unique insight into the organization’s business culture and approach.
In looking to build stronger relationships between TTOs and with industry, the initiative will offer candidates access to MRC Technology’s extensive drug development and commercialization expertise with the potential for future collaborations.
“The ENTENTE consortium would like to express its gratitude and thanks to MRC Technology for supporting the TTO development program,” commented Karine Baudin, Coordinator of ENTENTE.
Baudin continued, “Their willingness to share knowledge, expertise and time is an example of true professionalism and reinforces our joint desire to move healthcare forward. We hope this is the first step in a long term, sustainable initiative.”
Mike Johnson, Director of Corporate Partnerships at MRC Technology added, “We are very pleased to be contributing to this program. MRC Technology has a wealth of in-house expertise and has achieved considerable project success - we look forward to passing on our experience in translational research and technology transfer. The program opens up and adds strength to the TTO network which ultimately will help bring new medicines to patients faster.”
MRC Technology joins Ascenion (Germany), Bergen Teknologioverføring AS (Norway), Inserm Transfert (France) and Interface Entreprises-Université de Liège (Belgium) as the first hosting organizations to receive TTO candidates.
Key Cancer-Linked Proteins Thought to be ‘Undruggable’ Until NowNews
A new study published in Nature, conducted by an alliance between industry and academia involving the University of Liverpool, highlights a new approach to targeting key cancer-linked proteins, thought to be ‘undruggable’.READ MORE
Researchers Reveal How Superbug Secretes It’s ToxinNews
Monash University’s Biomedicine Discovery Institute (BDI) researchers have created the first high-resolution structure depicting a crucial part of the ‘superbug’ Pseudomonas aeruginosa. The image identifies the ‘nanomachine’ used by the highly virulent bacteria to secrete toxins, pointing the way for drug design targeting this.READ MORE